The effects of tamoxifen on endometrial insulin-like growth factor-1 expression

Obstetrics and Gynecology

Volumn 91, Issue 1, 1998, Pages 45-50

  Elkas, John ^a   Gray, Karen ^b   Howard, Leonard ^b   Petit, Nancy ^b   Pohl, Joseph ^b   Armstrong, Alicia ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

SOMATOMEDIN BINDING PROTEIN 1; SOMATOMEDIN C; TAMOXIFEN;

ARTICLE; BREAST CANCER; CELL PROLIFERATION; DRUG EFFECT; FEMALE; GENE EXPRESSION REGULATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MITOGENICITY; POSTMENOPAUSE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR UPREGULATION;

EID: 0031962194     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0029-7844(97)00549-8     Document Type: Article

References (10)

1. 1. Fisher B, Costantino JP, Redmond CK, Fisher ER, Wickerham DL, Cronin WM, et al. Endometrial cancer in tamoxifen-treated breast cancer patients: Findings from the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-14. J Natl Cancer Inst 1994;6: 527-37.
2. 2. Murphy LJ, Murphy LC, Friesen HG. Estrogen induces insulin-like growth factor-1 expression in the rat uterus. Mol Endocrinol 1987;1:445-50.
3. 3. Murphy L, Ghahary A. Uterine insulin-like growth factor-1: Regulation of expression and its role in estrogen-induced uterine proliferation. Endocr Rev 1990;11:443-53.
4. 4. Huynh H, Pollak M. Insulin-like growth factor 1 gene expression in the uterus is stimulated by tamoxifen and inhibited by the pure antiestrogen ICI 182780. Cancer Res 1993;53:5585-8.
5. 5. Adesanya OO, Zhou J, Bondy C. Sex steroid regulation of insulin-like growth factor system gene expression and proliferation in primate myometrium. J Clin Endocrinol Metab 1996;81:1967-74.
6. 6. Zhou J, Dsupin BA, Giudice LC, Bondy CA. Insulin-like growth factor system gene expression in human endometrium during the menstrual cycle. J Clin Endocrinol Metab 1994;79:1723-34.
7. 7. Montano MM, Katzenellenbogen BS. The quinone reductase gene: A unique estrogen receptor-regulated gene that is activated by antiestrogens. Proc Natl Acad Sci U S A 1997;94:2581-6.
8. 8. Mass RA, Bruning PF, Top B, Breedijk AJ, Peterse HL. Growth arrest associated changes of mRNA levels in breast cancer cells measured by semiquantitative RT-PCR: Potential early indicators of treatment response. Cancer Lett 1995;97:107-16.
9. 9. Le Roy X, Escot C, Browllet JP, Theillet C, Maudelonde T, Simony-Lafontaine J, et al. Decrease of c-erbB2 and c-myc RNA levels in tamoxifen treated breast cancer. Oncogene 1991;6:431-6.
10. 10. Silva IDCG, Salicioni AM, Russo IH, Higgy NA, Gerim LH, Russo J. Tamoxifen down-regulates CD36 messenger RNA levels in normal and neoplastic human breast tissues. Cancer Res 1997;57: 378-81.